BioCryst Pharmaceuticals Inc (BCRX)
4.38
-0.03
(-0.68%)
USD |
NASDAQ |
Apr 23, 16:00
4.37
-0.01
(-0.23%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Long Term Debt (Quarterly): 811.26M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 811.26M |
| September 30, 2023 | 833.18M |
| June 30, 2023 | 819.30M |
| March 31, 2023 | 746.93M |
| December 31, 2022 | 733.28M |
| September 30, 2022 | 713.65M |
| June 30, 2022 | 144.52M |
| March 31, 2022 | 604.46M |
| December 31, 2021 | 585.46M |
| September 30, 2021 | 162.05M |
| June 30, 2021 | 156.80M |
| March 31, 2021 | 153.04M |
| December 31, 2020 | 274.45M |
| September 30, 2020 | 75.93M |
| June 30, 2020 | 80.55M |
| March 31, 2020 | 80.21M |
| December 31, 2019 | 79.87M |
| September 30, 2019 | 79.53M |
| June 30, 2019 | 79.19M |
| March 31, 2019 | 78.85M |
| December 31, 2018 | 59.07M |
| September 30, 2018 | 58.93M |
| June 30, 2018 | 48.90M |
| March 31, 2018 | 50.40M |
| December 31, 2017 | 51.90M |
| Date | Value |
|---|---|
| September 30, 2017 | 51.68M |
| June 30, 2017 | 51.46M |
| March 31, 2017 | 51.24M |
| December 31, 2016 | 51.02M |
| September 30, 2016 | 50.80M |
| June 30, 2016 | 28.02M |
| March 31, 2016 | 27.91M |
| December 31, 2015 | 27.80M |
| September 30, 2015 | 30.00M |
| June 30, 2015 | 30.00M |
| March 31, 2015 | 30.00M |
| December 31, 2014 | 30.00M |
| September 30, 2014 | 30.00M |
| June 30, 2014 | 30.00M |
| March 31, 2014 | 30.00M |
| December 31, 2013 | 30.00M |
| September 30, 2013 | 30.00M |
| June 30, 2013 | 30.00M |
| March 31, 2013 | 30.00M |
| December 31, 2012 | 30.00M |
| September 30, 2012 | 30.00M |
| June 30, 2012 | 30.00M |
| March 31, 2012 | 30.00M |
| December 31, 2011 | 30.00M |
| September 30, 2011 | 30.00M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
75.93M
Minimum
Sep 2020
833.18M
Maximum
Sep 2023
379.67M
Average
162.05M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 1.725M |
| Protalix BioTherapeutics Inc | 20.25M |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |